Intermittent endocrine therapy for advan
β
Laurence H. Klotz; Harry W. Herr; Michael J. Morse; Willet F. Whitmore Jr.
π
Article
π
1986
π
John Wiley and Sons
π
English
β 491 KB
π 1 views
Twenty patients with advanced prostate cancer have been treated with an intermittent endocrine therapy schedule. Hormone therapy (diethylstilbestrol in 19 patients and flutamide in 1 patient) was administered until a clinical response was clearly demonstrated and then it was withheld until symptoms